British and Irish Hypertension Society response to ‘RAAS inhibitors in pregnancy, breastfeeding and women of childbearing potential: a review of national and international clinical practice guidelines’

IF 2.7 4区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Human Hypertension Pub Date : 2025-04-24 DOI:10.1038/s41371-025-01004-w

Luca Faconti, Louise Abrams, Bernadette Jenner, Eduard Shantsila, Sarah Partridge, Ian B. Wilkinson

引用次数: 0

Abstract

In their review of clinical practice guidelines on the use of renin-angiotensin-aldosterone system (RAAS) inhibitors, Greenlees and Delles call for more explicit advice on the use of these drugs among women of childbearing potential, during pregnancy and breastfeeding. In response, the British and Irish Hypertension Society (BIHS) highlight the key issues for clinicians to consider when prescribing RAAS inhibitors to hypertensive women and suggest areas where further research is needed.

查看原文本刊更多论文

英国和爱尔兰高血压学会对《妊娠、母乳喂养和生育潜力妇女的RAAS抑制剂：国家和国际临床实践指南综述》的回应

在他们对肾素-血管紧张素-醛固酮系统（RAAS）抑制剂临床应用指南的回顾中，Greenlees和Delles呼吁对有生育潜力的妇女、妊娠期和哺乳期使用这些药物提出更明确的建议。作为回应，英国和爱尔兰高血压协会（BIHS）强调了临床医生在给高血压女性开RAAS抑制剂处方时需要考虑的关键问题，并提出了需要进一步研究的领域。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Human Hypertension 医学-外周血管病

CiteScore

5.20

自引率

3.70%

发文量

126

审稿时长

6-12 weeks

期刊介绍： Journal of Human Hypertension is published monthly and is of interest to health care professionals who deal with hypertension (specialists, internists, primary care physicians) and public health workers. We believe that our patients benefit from robust scientific data that are based on well conducted clinical trials. We also believe that basic sciences are the foundations on which we build our knowledge of clinical conditions and their management. Towards this end, although we are primarily a clinical based journal, we also welcome suitable basic sciences studies that promote our understanding of human hypertension. The journal aims to perform the dual role of increasing knowledge in the field of high blood pressure as well as improving the standard of care of patients. The editors will consider for publication all suitable papers dealing directly or indirectly with clinical aspects of hypertension, including but not limited to epidemiology, pathophysiology, therapeutics and basic sciences involving human subjects or tissues. We also consider papers from all specialties such as ophthalmology, cardiology, nephrology, obstetrics and stroke medicine that deal with the various aspects of hypertension and its complications.